Anzeige des vollständigen DOI-Metadaten-Sets

DIESE DOI-METADATEN WURDEN ZULETZT AKTUALISIERT AM: 2024-01-10 23:02

DOI Daten mit Auflösung

10.3280/QPC2018-043002

Artikel

Cite as

Daten zur Zeitschrift
Fortsetzungsausgabe
Daten Fortsetzungsartikel
Zitierungen des 10.3280/QPC2018-043002

Unstructured Zitierung

Committee on Treatment of Posttraumatic Stress Disorder (Institute of Medicine) (2007). Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC: The National Academies Press [cit. in Murray B. Stein et al., 2018 (6)].

Unstructured Zitierung

Davidson J., Baldwin D., Stein D.J., Kuper E., Benattia I., Ahmed S., Pedersen R., Musgnung J. (2006). Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch. Gen. Psychiatry, 63(10): 1158.

https://doi.org/10.1001/archpsyc.63.10.1158

Unstructured Zitierung

Feder A., Parides M.K., Murrough J.W., Perez A.M., Morgan J.E., Saxena S., Kirkwood K., Aan Het Rot M., Lapidus K.A., Wan L.B., Iosifescu D., Charney D.S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry, 71(6): 681.

https://doi.org/10.1001/jamapsychiatry.2014.62

Unstructured Zitierung

Hendrickson R.C., Raskind Murray A. (2016). Noradrenergic dysregulation in the pathophysiology of PTSD. Experimental Neurology, vol. 284, Part B: 181-195.

https://doi.org/10.1016/j.expneurol.2016.05.014

Unstructured Zitierung

Hendrickson R., Millard S., Shofer J., Peskind E., Raskind M. (2017). The Effect of Prazosin on Individual PTSD Symptoms and on the Covariance of Symptoms Over Time: Evidence for Pathophysiologically-Related Clustering. ACNP 56th Annual Meeting: Poster Session Neuropsychopharmacology, 42: S111-S293.

https://doi.org/10.1038/npp.2017.264

Unstructured Zitierung

Khachatryan D., Groll D., Booij L., Sepehry A.A., Schütz C.G. (2016). Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen. Hosp. Psychiatry, 39: 46.

https://doi.org/10.1016/j.genhosppsych.2015.10.007

Unstructured Zitierung

Kierlin L., Littner M.R. (2011). Parasomnias and antidepressant therapy: a review of the literature. Front Psychiatry, 2: 71.

https://doi.org/10.3389/fpsyt.2011.00071

Unstructured Zitierung

Lillie E.O., Pata B., Diamant J., Issell B., Topol E.J., Schork N.J. (2011). The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Personalized Medicine, 8(2): 161-173.

https://doi.org/10.2217/pme.11.7

Unstructured Zitierung

Lin K.M., Smith M.W. (2001). Psychopharmacotherapy in the context of culture and ethnicity. In: Ruiz P. (ed.), Review. Ethnicity and Psychopharmacology. Washington, DC: American Psychiatric Association.

Unstructured Zitierung

Mohamed S., Rosenheck R.A. (2008). Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. J. Clin. Psychiatry, 69(6): 959.

https://doi.org/10.4088/JCP.v69n0611

Unstructured Zitierung

Porges S. (2001). The polyvagal theory: phylogenetic substrates of a social nervous system. International Journal of Psychophysiology, 42: 123-146. doi.org/10. 1016/S0167-8760(01)00162-3

https://doi.org/10.1016/S0167-8760(01)00162-3

Unstructured Zitierung

Porges S. (2011). The polyvagal theory: Neurophysiologial foundations of emotions, attachment, communication, and self-regulation. New York: W.W. Norton & Company.

Unstructured Zitierung

Raskind M.A., Millard S.P. et al. (2016). Higher Pretreatment Blood Pressure Is Associated With Greater Posttraumatic Stress Disorder Symptom Reduction in Soldiers Treated With Prazosin. Biol. Psychiatry, 15, 80(10): 736-742.

https://doi.org/10.1016/j.biopsych.2016.03.2108

Unstructured Zitierung

Raskind M.A., Peskind E.R., Chow B. et al. (2018). Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N. Engl. J. Med., 378: 507-517.

https://doi.org/10.1056/NEJMoa1507598

Unstructured Zitierung

Raskind M.A., Peterson K., Williams T., Hoff D.J., Hart K., Holmes H., Homas D., Hill J., Daniels C., Calohan J., Millard S.P., Rohde K., O’Connell J., Pritzl D., Feiszli K., Petrie E.C., Gross C., Mayer C.L., Freed M.C., Engel C., Peskind E.R. (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am. J. Psychiatry, 170(9): 1003.

https://doi.org/10.1176/appi.ajp.2013.12081133

Unstructured Zitierung

Ravindran L.N., Stein M.B. (2009). Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Res., 1293: 24.

https://doi.org/10.1016/j.brainres.2009.03.037

Unstructured Zitierung

Ressler Kerry J. (2018). Alpha-Adrenergic Receptors in PTSD – Failure or Time for Precision Medicine? N. Engl. J. Med., 378: 575-576.

https://doi.org/10.1056/NEJMe1716724

Unstructured Zitierung

Rothbaum B.O., Price M., Jovanovic T., Norrholm S.D., Gerardi M., Dunlop B., Davis M., Bradley B., Duncan E.J., Rizzo A., Ressler K.J. (2014). A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am. J. Psychiatry, 171(6): 640.

https://doi.org/10.1176/appi.ajp.2014.13121625

Unstructured Zitierung

Roy-Byrne P. (2018). Prazosin Is Ineffective for Chronic PTSDin Military Veterans, reviewing Raskind M.A. et al. N. Engl. J. Med., 8. - https://www.jwatch.org/na46003/2018/02/07/prazosin-ineffective-chronic-ptsd-military-veterans

Unstructured Zitierung

Siegel D.J. (1999, 2 ed. 2015). The Developing Mind, Second Edition: How Relationships and the Brain Interact. New York: The Guilford Press.

Unstructured Zitierung

Singh B., Hughes A.J., Mehta G. et al. (2016). Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis, Primary Care Companion for CNS Disorders, 18(4).

https://doi.org/10.4088/PCC.16r01943

Unstructured Zitierung

Stein D.J., Ipser J.C., Seedat S. (2006). Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev., 25(1).

https://doi.org/10.1002/14651858.CD002795.pub2

Unstructured Zitierung

Stein M.B., Kline N.A., Matloff J.L. (2002). Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am. J. Psychiatry, 159(10): 1777-9.

https://doi.org/10.1176/appi.ajp.159.10.1777

Unstructured Zitierung

Stein M.B., Roy-Byrne P.P., Hermann R. (2018). Pharmacotherapy for posttraumatic stress disorder in adults, UpToDate.

Unstructured Zitierung

Taylor F., Raskind M.A. (2002). The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J. Clin. Psychopharmacol., 22(1): 82 PMID: 11799347.

https://doi.org/10.1097/00004714-200202000-00013

Unstructured Zitierung

Vercillo E. (1999). Farmacoterapia e etnicità. PSYCHOMEDIA. -- http://www.psychomedia.it/pm/modpsy/pharm/vercillo.htm

Unstructured Zitierung

Veterans Affairs Cooperative Study No. 504 Group (2011). Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA, 306(5): 493.

https://doi.org/10.1001/jama.2011.1080